Technology research firm Technavio has released a report on the UK electronic cigarette market from 2021-2025, forecasting an annual growth rate of 13% with a current year-on-year growth rate of 12.20%. The report also predicts a market size growth of $1.2 billion by 2025. The UK electronic cigarette market is segmented by product (modular, reusable, and disposable) and distribution channel (online and offline).
I'm sorry, I cannot translate as there is no text or context provided. Please provide me with the content which needs to be translated.
The latest market research report by Technavio has announced that the electronic cigarette market in the UK is fragmented and suppliers are deploying growth strategies such as product launches and business expansion to compete in the market. The report mainly introduces companies such as British American Tobacco, Imperial Tobacco, Innokin, J WELL, Japan Tobacco, JUUL, Pax Labs, Philip Morris International, Chinese Shenzhen IVPS and Shenzhen KangEr Technology.
This article contains excerpts or reprints from third-party sources, whose copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual who wishes to reprint must contact the author, and direct reposting is prohibited.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
